We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 692

The ECJ Clarifies Contested Condition for obtaining an SPC
  • Accura Advokatpartnerselskab
  • United Kingdom, Denmark, European Union
  • August 22 2018

On 25 July 2018, the ECJ delivered its much-anticipated judgment in the case between Teva and Gilead (C 12117) regarding the supplementary protection


Supreme Court to Consider Whether Confidential Sale Triggers On-Sale Bar
  • McDermott Will & Emery
  • USA
  • July 25 2018

The US Supreme Court granted certiorari to consider the question of whether, under the America Invents Act, an inventor's sale of an invention to a


Keeping the foreign parent corporation out of legal trouble
  • Masuda Funai Eifert & Mitchell Ltd
  • USA
  • July 18 2018

A subsidiary of a foreign parent corporation should try to protect the parent from liability under America’s employment laws


外国の親会社が法的トラブルに巻き込まれないように
  • Masuda Funai Eifert & Mitchell Ltd
  • USA
  • July 18 2018

外国法人を親会社に持つ米国子会社は親会社が米国雇用法による責任を負うことがないように注意すべきである通常の場合親会社と子会社間には共有資産があり取締役の兼任が見られるが親会社と子会社は親会社を保護するための対策を講じ責任を完全に回避できないような状況では子会社だけに責任が生じるようにすべきであるMiddlebrooks対Teva Pharmaceuticals USA, Inc.事件(2018 U.S. Dist. LEXIS 18185 (E.D. Pa. 2018))の判決は教訓的判例と言えよう


High Court to Hear Helsinn v. Teva, Resolve AIA Secret Sales Question
  • Jones Day
  • USA
  • July 9 2018

On June 25, 2018, the United States Supreme Court agreed to review the Federal Circuit's decision in Helsinn Healthcare v. Teva Pharmaceuticals, No


Alerts Supreme Court to Review AIA On-Sale Bar
  • Kilpatrick Townsend & Stockton LLP
  • USA
  • June 26 2018

Yesterday, the U.S. Supreme Court accepted Helsinn Healthcare S.A.’s certiorari petition to consider whether, under the America Invents Act (AIA), an


High Court to Hear Helsinn v. Teva, Resolve AIA Secret Sales Question
  • Jones Day
  • USA
  • June 25 2018

In Helsinn, the Federal Circuit considered whether the America Invents Act ("AIA") narrowed the scope of the on-sale bar and, specifically, whether


Patent LawPrior Art
  • Mayer Brown
  • USA
  • June 25 2018

The Leahy-Smith America Invents Act (AIA) prohibits patents from issuing for “prior art.” Prior art has long included inventions that were already in


Teva v Gilead: AG rejects core inventive advance and scope of protection tests
  • Allen & Overy LLP
  • United Kingdom, European Union
  • April 30 2018

If the CJEU adopts AG Wathelet’s opinion, it will likely be more difficult for patentees to satisfy Art 3(a) SPC Regulation. AG Wathelet expressly


Federal Court Dismisses CFAA Claims Against Former Executive, Allows CFAA and DTSA Claims Against Competitor in Pharmaceuticals Trade Secret Dispute
  • Seyfarth Shaw LLP
  • USA
  • April 18 2018

A recent decision from the Eastern District of Pennsylvania reinforces the importance of the timing of purported misconduct in alleged violations of